DeepSeeks Emergence Unlikely to Derail US AI Leaders Analysts Suggest White House Gunmans Prior Secret Service Encounters Raise Security Concerns Potentially Weighing on Investor Sentiment European Markets Poised for Mixed Open as Investors Weigh Fragile USIran Truce ByteDance Weighs Up to 89 Billion AI Investment Signaling Aggressive Push in Chinas Tech Race Bitcoin Below 100000 Market Dynamics and Investor Considerations UK Secures 37bn Trade Agreement with Gulf Cooperation Council States Eliminating 580m in Tariffs TRMD Q1 2026 Earnings EPS Surprises to the Upside Amid Cautious Market Sentiment BGMS Q3 2024 Earnings Narrowing Loss Beats Estimates by Wide Margin ASML Q1 2026 Earnings EPS Beats Estimates with 713 Surprise as Stock Holds Steady ACT Q1 2026 Earnings EPS Beats Estimates as Enact Holdings Posts Solid Underwriting Results BDTX Q1 2026 Earnings EPS Beat but Stock Retreats 36 on Biotech Volatility STRL Q1 2026 Earnings Stellar EPS Beat Driven by Operational Efficiency Parke Bancorp Inc PKBK Hovers Near Flatline as Traders Weigh Support and Resistance Levels Nucor Corporation NUE Edges Higher Amid Steel Sector Resilience Unusual Machines UMAC Surges 57 as Momentum Builds Above Key Support Ekso Bionics EKSO Moves Higher as Stock Tests Resistance Near 1239 Ennis Inc EBF Edges Higher Amid Modest Gains Holds Above Key Support Tactile Systems Technology Q1 2026 Earnings NarrowerThanExpected Loss Masks Lack of Revenue Details Alexanders Inc ALX Q1 2026 Earnings Solid EPS Performance Amid Limited Disclosures SRFM Q1 2026 Earnings EPS Surprise Beats Estimates Amid PreRevenue Operations GROW Q1 2026 Earnings Profitability Surprises with EPS of 023 Despite No Revenue Disclosure APG Q1 2026 Earnings EPS Exceeds Expectations Amid Steady Operational Performance UHAL Q1 2026 Earnings Significant EPS Miss Despite Modest Stock Gain UnitedHealth Group UNH Appears Among Top Hedge Fund Dividend Picks Amid Analyst Optimism National Research Corporation NRC Q1 2026 Earnings EPS of 021 Reported Amid Limited Market Expectations Jazz Pharmaceuticals JAZZ Shares Dip 132 as Stock Tests Key Support Levels